Admitting that there is pressure from big pharma companies to change the Indian patent law, the Arun Maira-led high-level committee…
The British arm of Ranbaxy Labs is in the process of recalling three drugs from the UK market.
While deciding against imposing any limit on FDI in the pharma sector, the Arun Maira headed high-level committee has mooted…
Over-prescription of medicines, a side effect of unhealthy competition among makers of branded drugs, could decline, with a new regulation…
The government should emulate the recent FDI policy approach of multi-brand retail sector while taking a final decision on whether…
Generic drugs helped the US government save almost $1 trillion since 1999, according to an estimate of an IMS Health…
One of the fastest growing Indian drug makers, Macleods Pharma has settled a patent dispute with Swiss pharma giant Novartis…
Vinita Bali, MD, Britannia Industries shares with FE?s Soma Das the need for a separate nutrition policy, the need for…
Prescription formulations of paracetamol in combination with other drugs can?t have a weight of more than 325 mg of the…
In a setback to Hyderabad-based Natco Pharma, the Israeli drug giant Teva Pharma claims to have won the first round…
An inter-ministerial group mandated to decide on restricting FDI in pharma sector is witnessing a near vertical split among ministries.
Hit by a slump in the sales of anti-infectives, gastrointestinal drugs and analgesic, the pharma growth in the domestic retail…
Drug companies looking to test their experimental drugs on Indians will not find human lives cheap any more. According to…
Ameera Shah, the CEO of Metropolis Healthcare, one of the top three diagnostic chains in the country, shares her overseas…
Lupin?s managing director Kamal Sharma tells FE?s Soma Das that the company management has no plans to sell its India…
The domestic pharma industry continued to clock double-digit growth of 13.5% during the April-June quarter of the financial year.
Bangalore-based sterile injectible firm, Strides Arcolab, is close to settling its ongoing patent dispute with Tokyo-based innovator firm Astella Pharma…
Even as most big hospital groups seem to have sorted out their differences with public sector health insurance players to…
